FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Anti-HCV Next
K Number: K252424
·
Decision Apr 28, 2026
Classifications
1
FEI Numbers
24
Registration Numbers
24
Same Product Code
1
Applicant Total
883
Review Days
270
Basic Information
- Device Name
- Anti-HCV Next
- K Number
- K252424
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.3169
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Abbott Laboratories
- Date Received
- August 1, 2025
- Decision Date
- April 28, 2026
- Product Code
- MZO
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MZO | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MZO), ordered by most recent decision date.
View allOther Clearances by Abbott Laboratories
| K Number | Device Name | ||
|---|---|---|---|
| K243500 | ARCHITECT iGentamicin | Jul 9, 2025 | Substantially Equivalent |
| K243168 | Alinity i Rubella IgG | Jun 20, 2025 | Substantially Equivalent |
| K243283 | Alinity h-series System | Feb 20, 2025 | Substantially Equivalent |
| K233932 | Alinity i Toxo IgM | Aug 30, 2024 | Substantially Equivalent |
| K232669 | TBI | Sep 29, 2023 | Substantially Equivalent |
| K222850 | HAVAb IgG II | Aug 10, 2023 | Substantially Equivalent |
| K220031 | Alinity h-series System | Aug 4, 2023 | Substantially Equivalent |
| K220282 | i-STAT PTplus Cartridge with the i-STAT 1 System | Jul 14, 2023 | Substantially Equivalent |
| K230937 | Alinity i Total ß-hCG Reagent Kit, GLP systems Track | Jun 5, 2023 | Substantially Equivalent |
| K230790 | Alinity i Total B-hCG Reagent Kit, Alinity c Glucose Reagent Kit, Alinity c ICT Sample Diluent, Alinity ci-series | May 19, 2023 | Substantially Equivalent |